European Archives - Page 949 of 982 - European Medical Journal

Continue
24 Nov 2014

The Aetiopathogenesis of Psoriasis in 2014: An Update

Psoriasis is a common inflammatory skin disease and its immuno-aetiopathogenesis has been extensively studied, using both human clinical samples and…
24 Nov 2014

Primary Cutaneous Neutrophilic Disorders

The ‘classical neutrophilic dermatoses’ comprise a spectrum of disorders characterised by rash and neutrophilia. The defining histopathological finding…
24 Nov 2014

Neutrophilic Dermatoses Revisited

The neutrophilic dermatoses (ND) comprise a group of heterogeneous disorders characterised by inflammatory skin lesions that histologically show an…
24 Nov 2014

Skin pH in the Elderly and Appropriate Skin Care

The acidic skin surface pH (pHSS) plays a crucial role in the maintenance of a vital stratum corneum (SC) and an intact epidermal barrier.
24 Nov 2014

Isotretinoin and Psychiatric Effects

Isotretinoin is a vitamin A derivative that has been commonly used by dermatologists for the treatment of acne. Isotretinoin has many dose-related…
24 Nov 2014

Methylisothiazolinone and Methylchloroisothiazolinone: New Insights

Methylisothiazolinone (MI), along with Kathon™ CG (methylchloroisothiazolinone/MI), are widely used preservatives to prevent bacterial overgrowth in…
24 Nov 2014

Gram-Negative Bacterial Toe Web Intertrigo

Gram-negative infection of the toe web space is less frequent than dermatophytes and yeasts, but it is more challenging, especially with the involvement…
November 2014

EMJ Dermatology 2014

Welcome to the new edition of the European Medical Journal Dermatology. We have combined leading, peer-reviewed editorials with reviews from the European…
EMJ
21 Nov 2014

Immune Checkpoint Inhibitors May Work in Brain Cancers

LUGANO/GENEVA, Switzerland, 21 November 2014 – New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented…
EMJ
21 Nov 2014

Possibilities for Personalised Vaccines Revealed at ESMO Symposium

LUGANO/GENEVA, Switzerland, 21 November 2014 – The possibilities for personalised vaccines in all types of cancer are revealed today in a lecture from…